agilon health (NYSE:AGL) Given New $2.00 Price Target at Stifel Nicolaus

agilon health (NYSE:AGLFree Report) had its target price cut by Stifel Nicolaus from $7.00 to $2.00 in a research note published on Tuesday,Benzinga reports. They currently have a hold rating on the stock.

A number of other analysts have also weighed in on the stock. Deutsche Bank Aktiengesellschaft cut their price objective on shares of agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a research note on Friday, August 9th. Citigroup reiterated a “sell” rating and issued a $2.50 price objective (down previously from $7.00) on shares of agilon health in a research note on Tuesday, October 29th. Bank of America lowered shares of agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price objective on the stock. in a research note on Wednesday, October 2nd. Benchmark reiterated a “buy” rating and issued a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Finally, TD Cowen cut their price objective on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $6.38.

Check Out Our Latest Research Report on agilon health

agilon health Trading Down 7.3 %

Shares of agilon health stock opened at $1.59 on Tuesday. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 12-month low of $1.58 and a 12-month high of $13.76. The firm has a market capitalization of $653.05 million, a price-to-earnings ratio of -1.69 and a beta of 0.60. The firm’s 50 day simple moving average is $3.05 and its two-hundred day simple moving average is $4.86.

agilon health (NYSE:AGLGet Free Report) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the previous year, the company posted ($0.06) EPS. Analysts predict that agilon health will post -0.43 EPS for the current year.

Insider Buying and Selling at agilon health

In other agilon health news, CEO Steven Sell purchased 20,000 shares of the firm’s stock in a transaction dated Thursday, September 12th. The shares were purchased at an average cost of $3.36 per share, with a total value of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at approximately $227,102.40. This represents a 42.03 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

A number of institutional investors have recently made changes to their positions in AGL. J.Safra Asset Management Corp boosted its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after purchasing an additional 3,625 shares during the period. Point72 Asia Singapore Pte. Ltd. acquired a new position in agilon health in the 3rd quarter valued at $28,000. City State Bank purchased a new position in shares of agilon health in the 3rd quarter valued at about $52,000. CWM LLC increased its holdings in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock valued at $59,000 after purchasing an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC acquired a new stake in agilon health in the 2nd quarter valued at about $60,000.

agilon health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Analyst Recommendations for agilon health (NYSE:AGL)

Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.